Most Read Articles
Pearl Toh, 5 days ago
Mepolizumab added on to standard of care for patients with severe eosinophilic asthma better improves health-related quality of life (HRQOL), along with improved asthma symptoms and lung function compared with placebo, according to the MUSCA* study.
Pearl Toh, 4 days ago
Treatment with abiraterone acetate and prednisone for metastatic prostate cancer (mPC) in patients who responded poorly to initial androgen-deprivation therapy (ADT) showed encouraging results with favourable overall survival (OS) to historical controls, although the prespecified criteria for a positive result was not met , according to the S1014* trial.
3 days ago
Blood pressure (BP) ≥140/90 mm Hg appears to increase the risk of maternal complications and adverse foetal outcomes, irrespective of the number of medications used, a study suggests. However, the greatest risk is observed among pregnant women taking multiple agents and whose BP levels are within the aforementioned range.
5 days ago
Relapse after randomization is more likely to occur in patients with severe baseline hallucinations, reports a new study. In addition, the presence of baseline hallucinations is associated with a greater risk of relapse after discontinuation of risperidone vs continued risperidone treatment.

Early onset of hot flashes may signal heart disease risk

Elvira Manzano
10 days ago

Early onset of hot flashes (sudden feelings of warmth) in the course of menopause is associated with a poorer endothelial function in women in a new study, a finding investigators say could signal emerging vascular heart disease.

“We used to think that hot flashes were just annoying symptoms that many women just tried to endure,” said lead author Dr Rebecca Thurston from the Department of Psychiatry, University of Pittsburgh School of Medicine in Pittsburgh, Philadelphia, US. “Our data now suggest that hot flashes might indicate adverse changes in the blood vessels of some women during midlife which might not be medically benign over time.”

Thurston and her team sought to examine the relationship between physiologically assessed hot flashes and endothelial function in 272 nonsmoking women (age 40 to 69 years) who were either late perimenopausal (2 to 12 months amenorrhoea) or postmenopausal (≥12 months amenorrhoea). [Menopause 2017;doi;10.1097/GME.0000000000000857]

On average, the women were about 54 years of age and had a relatively favourable cardiovascular (CV) risk factor profile. Endothelial function was assessed using brachial artery flow-mediated dilation (FMD); ambulatory hot flashes were monitored.

Excluded from the analysis were women with cardiovascular disease, neoplasia, hysterectomy or bilateral oophorectomy, kidney failure, seizures, Parkinson’s disease, Raynaud’s phenomenon, or current pregnancy.

Among the younger tertile of women (age 40-53 years), the presence of hot flashes (p = 0.01), was associated with lower flow-mediated dilation (FMD), indicating poorer endothelial function. Greater frequency of physiologic hot flashes was also associated with poorer FMD in the younger women (p = 0.03, multivariable).The associations occurred independent of other CV risk factors and estradiol levels. Of note, the associations were absent in the older women (age 54-60 years).

“Impairment in endothelial function is an initiating event in the atherosclerotic process,” said. “Among early midlife women in this study, frequent hot flashes may mark emerging vascular dysfunction.”

Hot flashes are the hallmark symptom of the menopause transition. In fact, up to 70 percent of women experience hot flashes and night sweats during menopause, said Thurston. The current data suggest that early-onset hot flashes may be a red flag that can help pinpoint women who are at increased CV risk and who may need rigorous assessment for early prevention.

“Physiologically assessed hot flashes and endothelial function among midlife women may offer valuable information for healthcare providers working to assess the risk of heart disease in their menopausal patients,” Thurston concluded. 


Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 5 days ago
Mepolizumab added on to standard of care for patients with severe eosinophilic asthma better improves health-related quality of life (HRQOL), along with improved asthma symptoms and lung function compared with placebo, according to the MUSCA* study.
Pearl Toh, 4 days ago
Treatment with abiraterone acetate and prednisone for metastatic prostate cancer (mPC) in patients who responded poorly to initial androgen-deprivation therapy (ADT) showed encouraging results with favourable overall survival (OS) to historical controls, although the prespecified criteria for a positive result was not met , according to the S1014* trial.
3 days ago
Blood pressure (BP) ≥140/90 mm Hg appears to increase the risk of maternal complications and adverse foetal outcomes, irrespective of the number of medications used, a study suggests. However, the greatest risk is observed among pregnant women taking multiple agents and whose BP levels are within the aforementioned range.
5 days ago
Relapse after randomization is more likely to occur in patients with severe baseline hallucinations, reports a new study. In addition, the presence of baseline hallucinations is associated with a greater risk of relapse after discontinuation of risperidone vs continued risperidone treatment.